Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
147M
-
Number of holders
-
1091
-
Total 13F shares, excl. options
-
126M
-
Shares change
-
-2.1M
-
Total reported value, excl. options
-
$43.5B
-
Value change
-
-$567M
-
Put/Call ratio
-
1.04
-
Number of buys
-
438
-
Number of sells
-
-568
-
Price
-
$346.27
Significant Holders of BIOGEN INC. - COM (BIIB) as of Q2 2021
1,273 filings reported holding BIIB - BIOGEN INC. - COM as of Q2 2021.
BIOGEN INC. - COM (BIIB) has 1,091 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 126M shares
of 147M outstanding shares and own 85.61% of the company stock.
Largest 10 shareholders include PRIMECAP MANAGEMENT CO/CA/ (16.5M shares), BlackRock Inc. (13.2M shares), VANGUARD GROUP INC (11.8M shares), STATE STREET CORP (6.68M shares), WELLINGTON MANAGEMENT GROUP LLP (5.6M shares), JPMORGAN CHASE & CO (5.35M shares), Clearbridge Investments, LLC (3.57M shares), GEODE CAPITAL MANAGEMENT, LLC (2.89M shares), NORTHERN TRUST CORP (2.07M shares), and NORGES BANK (1.82M shares).
This table shows the top 1091 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.